Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

ALIREZA FARABI

Allopathic & Osteopathic Physicians Internal Medicine Infectious Disease

NPI
1598889008
CMS profile
72414
Location
LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$105,680.29

210 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
ViiV Healthcare Company $67,126.66 108
Gilead Sciences, Inc. $28,997.47 69
Napo Pharmaceuticals Inc $8,392.97 9
ABBVIE INC. $583.19 7
Merck Sharp & Dohme LLC $301.09 11
EMD Serono, Inc. $141.90 4
Abbott Laboratories $137.01 2

Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

ALIREZA FARABI

NPI 1598889008 · CMS profile ID 72414

Allopathic & Osteopathic Physicians / Internal Medicine / Infectious Disease

LAS VEGAS, NV

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1598889008?year=2025&recipient=provider&page=2#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
ALIREZA FARABI, NPI 1598889008, CMS profile ID 72414. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1598889008?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
APA 7
IndustryPayments. (2026). ALIREZA FARABI, NPI 1598889008, CMS profile ID 72414. General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1598889008?year=2025&recipient=provider&page=2#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e.
Bluebook
ALIREZA FARABI, NPI 1598889008, CMS profile ID 72414, IndustryPayments, General Payments, PY2025; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 2 of 5; records 51–100 of 210 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb0b1734-1410-429d-92f6-3f4b35218e5e. https://industrypayments.org/provider/npi-1598889008?year=2025&recipient=provider&page=2#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

210 matching records · $105,680.29 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 210 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 51–100 of 210.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ViiV Healthcare Company $1,300.0009/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189566077 CMS
ViiV Healthcare Company $27.4809/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189535748 CMS
Merck Sharp & Dohme LLC $31.7909/09/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238282067 CMS
ABBVIE INC. $149.6609/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201836543 CMS
Gilead Sciences, Inc. $24.2309/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234482120 CMS
ViiV Healthcare Company $93.7309/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189554096 CMS
ViiV Healthcare Company $31.0309/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189571591 CMS
ViiV Healthcare Company $9.0009/02/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189550457 CMS
Napo Pharmaceuticals Inc $17.8608/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1223619180 CMS
ViiV Healthcare Company $32.8408/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189556340 CMS
EMD Serono, Inc. $41.1108/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1236872570 CMS
Gilead Sciences, Inc. $23.5708/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234488734 CMS
ViiV Healthcare Company $8.6508/26/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189581708 CMS
ViiV Healthcare Company $24.9408/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189600320 CMS
ViiV Healthcare Company $21.4808/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189516520 CMS
ViiV Healthcare Company $22.7508/22/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189589955 CMS
ABBVIE INC. $9.5808/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1201836541 CMS
Gilead Sciences, Inc. $5.1408/19/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234602260 CMS
ViiV Healthcare Company $9.2608/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189576164 CMS
Gilead Sciences, Inc. $23.9208/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234485166 CMS
Merck Sharp & Dohme LLC $26.0508/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1238382706 CMS
ViiV Healthcare Company $16.7808/08/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189611699 CMS
ViiV Healthcare Company $6.6308/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189514294 CMS
ViiV Healthcare Company $9,750.0008/05/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189551591 CMS
ViiV Healthcare Company $7.7807/31/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189606069 CMS
ViiV Healthcare Company $6.9707/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189562526 CMS
Gilead Sciences, Inc. $1,980.0007/25/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234357186 CMS
ViiV Healthcare Company $12.1707/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189557502 CMS
ViiV Healthcare Company $32.1607/25/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189583813 CMS
Gilead Sciences, Inc. $2,450.0007/24/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234356360 CMS
Gilead Sciences, Inc. $474.5007/24/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1234366111 CMS
Gilead Sciences, Inc. $14.3007/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234575823 CMS
Gilead Sciences, Inc. $7.6607/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234592974 CMS
Gilead Sciences, Inc. $150.0007/18/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234375066 CMS
ViiV Healthcare Company $2,600.0007/18/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189601599 CMS
Gilead Sciences, Inc. $117.8507/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234392120 CMS
ViiV Healthcare Company $34.5507/17/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189592564 CMS
Gilead Sciences, Inc. $26.9907/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234458546 CMS
ViiV Healthcare Company $4.4007/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189611249 CMS
Gilead Sciences, Inc. $29.0907/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234443861 CMS
Gilead Sciences, Inc. $735.0007/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1234359587 CMS
Gilead Sciences, Inc. $31.9307/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1234428400 CMS
ViiV Healthcare Company $1,625.0007/07/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/2026 1189596762 CMS
ViiV Healthcare Company $27.0407/03/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189544931 CMS
ViiV Healthcare Company $127.4606/28/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/2026 1189511298 CMS
ViiV Healthcare Company $25.2306/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189574896 CMS
ViiV Healthcare Company $28.9706/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189597912 CMS
ViiV Healthcare Company $65.3906/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189630237 CMS
ViiV Healthcare Company $45.3606/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189534904 CMS
ViiV Healthcare Company $17.6506/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1189561902 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $90,301.38 191
PY2020 $51,162.91 86
PY2021 $54,053.21 122
PY2022 $78,789.22 144
PY2023 $104,926.10 209
PY2024 $103,040.58 204
PY2025 $105,680.29 210

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $531,758.60 22
PY2024 Principal investigator $662,058.50 30
PY2023 Recipient $3,601.48 17
PY2023 Principal investigator $157,673.69 9
PY2022 Principal investigator $13,290.14 10
PY2021 Principal investigator $8,713.89 7
PY2020 Principal investigator $9,596.25 4
PY2019 Principal investigator $17,761.63 11

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

22 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 ViiV Healthcare Company $4,120.74 12/17/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190317371
Principal investigator 1 Theratechnologies Inc. $232,720.00 12/02/2025 Non-covered Recipient Entity
Las Vegas Research Center, Inc.
A Prospective and Retrospective Observational Study of Multidrug-Resistant Patient Outcomes with and without Ibalizumab in a Real-World Setting: United States (PROMISE-US) No dispute reported 06/30/2026 1249666491
Principal investigator 1 ABBVIE INC. $6,305.00 11/04/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202520745
Principal investigator 1 ABBVIE INC. $13,288.17 10/09/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202513887
Principal investigator 1 ViiV Healthcare Company $8,700.00 09/24/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
PREFER-LA PATIENT REPORTED EXP AND BENEFIT OF TREATMENT W CABENUVA No dispute reported 06/30/2026 1190317369
Principal investigator 1 ABBVIE INC. $3,700.00 09/10/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER
Study to Evaluate Adverse Events and Change in Disease Activity in Adult and Adolescent Participants With Acute Hepatitis C Virus (HCV) Infection on Treatment With Oral Tablets of Glecaprevir (GLE) Pibrentasvir (PIB) No dispute reported 06/30/2026 1202510388
Principal investigator 1 ABBVIE INC. $15,724.67 09/03/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202507153
Principal investigator 1 ABBVIE INC. $17,256.21 08/05/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202501452
Principal investigator 1 ViiV Healthcare Company $5,097.82 07/09/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190317365
Principal investigator 1 ViiV Healthcare Company $2,500.00 07/09/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190317373
Principal investigator 1 ABBVIE INC. $16,400.80 07/02/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202494325
Principal investigator 1 Gilead Sciences, Inc. $66,501.00 06/17/2025 Non-covered Recipient Entity
Las Vegas Research Center
A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF after Discontinuing Injectable CAB + RPV No dispute reported 06/30/2026 1229202589
Principal investigator 1 Gilead Sciences, Inc. $12,950.00 06/17/2025 Non-covered Recipient Entity
Las Vegas Research Center
A Phase 4 Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Oral B/F/TAF after Discontinuing Injectable CAB + RPV No dispute reported 06/30/2026 1229202595
Principal investigator 1 ABBVIE INC. $11,408.10 06/03/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202488203
Principal investigator 1 ABBVIE INC. $15,527.00 05/07/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202483391
Principal investigator 1 ViiV Healthcare Company $3,299.40 04/16/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190317363
Principal investigator 1 ViiV Healthcare Company $1,579.21 04/09/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190317361
Principal investigator 1 ABBVIE INC. $17,221.80 04/03/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202469188
Principal investigator 1 ViiV Healthcare Company $4,343.30 03/19/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE 3B, MULTICENTER, SINGLE-ARM, OPEN-LABEL STUDY EVALUATING THE E No dispute reported 06/30/2026 1190317103
Principal investigator 1 ABBVIE INC. $32,558.50 03/07/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202459562
Principal investigator 1 ABBVIE INC. $33,215.00 02/06/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
M19-965 - A Study to Assess Change in Disease Activity Adverse Events and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion of Budigalimab and/or ABBV-382 No dispute reported 06/30/2026 1202448269
Principal investigator 1 ViiV Healthcare Company $7,341.88 01/24/2025 Non-covered Recipient Entity
LAS VEGAS RESEARCH CENTER INC
A PHASE IIIB, MULTI-CENTER, NON-RANDOMIZED, PARALLEL-GROUP, OPEN-LABEL No dispute reported 06/30/2026 1190317367